Screener
NewAmsterdam Pharma Company NAMS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on the most recent quarter.
The source filing: NewAmsterdam Pharma Company’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333824
FAQ
- What is NewAmsterdam Pharma Company's current ratio?
- NewAmsterdam Pharma Company (NAMS) reported current ratio of 9× in Q2 2026.
- How has NewAmsterdam Pharma Company's current ratio changed year-over-year?
- NewAmsterdam Pharma Company's current ratio decreased by 57.2% year-over-year, from 21.1× to 9×.
- What is the long-term trend for NewAmsterdam Pharma Company's current ratio?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's current ratio has grown at a -15.9% compound annual growth rate (CAGR), from 13.3× to 7.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about NewAmsterdam Pharma Company's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude